Term ends Nov 9, 2029 · High confidence
20-year base term ends Jun 13, 2028
Held by Merck Sharp & Dohme B.V.
Filed Nov 13, 2017 as application 15/810,892 · Granted Sep 14, 2021
Base term plus 514 days of patent term adjustment (USPTO delay)
Today
2008
2029
Clock starts
Jun 13, 2008
Jun 13, 2008
Term ends
Nov 9, 2029
Nov 9, 2029
Granted
Sep 14, 2021
Sep 14, 2021
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
514
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,556,957, to Nov 9, 2029. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 514 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 13, 2008, when application PCT/US2008/007463, the earliest non-provisional in its chain, was filed (this one was filed Nov 13, 2017) | Jun 13, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +514 days, USPTO patent term adjustment record | Nov 9, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,556,957) | resolves to Nov 9, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 9, 2029 | High confidence |
This family
| Application PCT/US2008/007463 | PCT application no patent term | no patent term |
| US 8,354,509 | In force Dec 2028 | Dec 2028 |
| US 8,900,587 | In force Aug 2028 | Aug 2028 |
| US 8,952,136 | In force Oct 2028 | Oct 2028 |
| US 9,834,605 | In force May 2029 | May 2029 |
| US 11,117,961 | this patent Nov 2029 | Nov 2029 |
| Application 17/469,359 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 15, 2018 Reel 45807, frame 151 | Carven, Gregory John; Van Eenennaam, Hans; Dulos, Gradus Johannes | N.V. Organon | Assignment of Assignor's Interest |
| May 15, 2018 Reel 45807, frame 868 | MSD Oss B.V. | Organon Biosciences Nederland B.V. | Merger |
| May 15, 2018 Reel 46154, frame 597 | Organon Biosciences Nederland B.V. | Merck Sharp & Dohme B.V. | Merger |
| May 15, 2018 Reel 46155, frame 186 | N.V. Organon | MSD Oss B.V. | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2029
Term ends Nov 9, 2029. Maintenance fees still fall due before then
Note
The 514 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 10,556,957, ends no earlier than this term, so it caps nothing.
Citations
5
later US patents cite this one
That is above the median of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.